Literature DB >> 8414973

Mutagenesis analysis of a hepatitis delta virus genomic ribozyme.

H N Wu1, J Y Lee, H W Huang, Y S Huang, T G Hsueh.   

Abstract

We conducted extensive mutagenesis analysis on a hepatitis delta virus (HDV) genomic ribozyme to study the sequence specificity of certain region and to derive the secondary structure associated with the catalytic core. The results confirmed that the autocatalytic domain of HDV genomic RNA contained four base-pairing regions as predicted in the 'pseudo-knot' model [Perrotta & Been (1990) Nature 350, 434-436]. The size and sequence of one of the base-pairing regions, i. e. stem-and-loop, could be flexible. Helix 3 and the first basepair of helix 1 required specific sequence to retain self-cleavage activity. The structural requirement of helix 2 was less stringent than the other base-pairing regions. Moreover, the size of helix 1 affected self-cleavage whereas the length of hinge could be variable even though the first three residues of hinge had stringent sequence requirement.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8414973      PMCID: PMC310049          DOI: 10.1093/nar/21.18.4193

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  18 in total

1.  Secondary structure of the self-cleaving RNA of hepatitis delta virus: applications to catalytic RNA design.

Authors:  M D Been; A T Perrotta; S P Rosenstein
Journal:  Biochemistry       Date:  1992-12-01       Impact factor: 3.162

2.  Mutagenesis analysis of the self-cleavage domain of hepatitis delta virus antigenomic RNA.

Authors:  H N Wu; Z S Huang
Journal:  Nucleic Acids Res       Date:  1992-11-25       Impact factor: 16.971

3.  Random mutations to evaluate the role of bases at two important single-stranded regions of genomic HDV ribozyme.

Authors:  P K Kumar; Y A Suh; H Miyashiro; F Nishikawa; J Kawakami; K Taira; S Nishikawa
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

4.  Cleavage of oligoribonucleotides by a ribozyme derived from the hepatitis delta virus RNA sequence.

Authors:  A T Perrotta; M D Been
Journal:  Biochemistry       Date:  1992-01-14       Impact factor: 3.162

5.  Sequence and structure of the catalytic RNA of hepatitis delta virus genomic RNA.

Authors:  H N Wu; Y J Wang; C F Hung; H J Lee; M M Lai
Journal:  J Mol Biol       Date:  1992-01-05       Impact factor: 5.469

6.  A small catalytic oligoribonucleotide.

Authors:  O C Uhlenbeck
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

7.  Point and compensation mutations to evaluate essential stem structures of genomic HDV ribozyme.

Authors:  P K Kumar; Y A Suh; K Taira; S Nishikawa
Journal:  FASEB J       Date:  1993-01       Impact factor: 5.191

8.  Modification interference analysis of a self-cleaving RNA from hepatitis delta virus.

Authors:  M G Belinsky; E Britton; G Dinter-Gottlieb
Journal:  FASEB J       Date:  1993-01       Impact factor: 5.191

9.  Structure, sequence and expression of the hepatitis delta (delta) viral genome.

Authors:  K S Wang; Q L Choo; A J Weiner; J H Ou; R C Najarian; R M Thayer; G T Mullenbach; K J Denniston; J L Gerin; M Houghton
Journal:  Nature       Date:  1986 Oct 9-15       Impact factor: 49.962

10.  Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA.

Authors:  S Makino; M F Chang; C K Shieh; T Kamahora; D M Vannier; S Govindarajan; M M Lai
Journal:  Nature       Date:  1987 Sep 24-30       Impact factor: 49.962

View more
  11 in total

1.  Ribozyme-based gene-inactivation systems require a fine comprehension of their substrate specificities; the case of delta ribozyme.

Authors:  Lucien Junior Bergeron; Jonathan Ouellet; Jean-Pierre Perreault
Journal:  Curr Med Chem       Date:  2003-12       Impact factor: 4.530

2.  Mechanistic characterization of the HDV genomic ribozyme: the cleavage site base pair plays a structural role in facilitating catalysis.

Authors:  Andrea L Cerrone-Szakal; Durga M Chadalavada; Barbara L Golden; Philip C Bevilacqua
Journal:  RNA       Date:  2008-07-24       Impact factor: 4.942

3.  Substrate specificity of delta ribozyme cleavage.

Authors:  S Ananvoranich; J P Perreault
Journal:  J Biol Chem       Date:  1998-05-22       Impact factor: 5.157

4.  Detailed analysis of base preferences at the cleavage site of a trans-acting HDV ribozyme: a mutation that changes cleavage site specificity.

Authors:  F Nishikawa; H Fauzi; S Nishikawa
Journal:  Nucleic Acids Res       Date:  1997-04-15       Impact factor: 16.971

5.  Wobble pairs of the HDV ribozyme play specific roles in stabilization of active site dynamics.

Authors:  Kamali N Sripathi; Pavel Banáš; Kamila Réblová; Jiří Šponer; Michal Otyepka; Nils G Walter
Journal:  Phys Chem Chem Phys       Date:  2015-02-28       Impact factor: 3.676

6.  3-D models of the antigenomic ribozyme of the hepatitis delta agent with eight new contacts suggested by sequence analysis of 188 cDNA clones.

Authors:  A D Branch; J A Polaskova
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

7.  Core sequences and a cleavage site wobble pair required for HDV antigenomic ribozyme self-cleavage.

Authors:  A T Perrotta; M D Been
Journal:  Nucleic Acids Res       Date:  1996-04-01       Impact factor: 16.971

8.  A catalytic metal ion interacts with the cleavage Site G.U wobble in the HDV ribozyme.

Authors:  Jui-Hui Chen; Bo Gong; Philip C Bevilacqua; Paul R Carey; Barbara L Golden
Journal:  Biochemistry       Date:  2009-02-24       Impact factor: 3.162

9.  A pseudoknot ribozyme structure is active in vivo and required for hepatitis delta virus RNA replication.

Authors:  K S Jeng; A Daniel; M M Lai
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  The genomic HDV ribozyme utilizes a previously unnoticed U-turn motif to accomplish fast site-specific catalysis.

Authors:  Jana Sefcikova; Maryna V Krasovska; Jirí Sponer; Nils G Walter
Journal:  Nucleic Acids Res       Date:  2007-03-02       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.